Revenue momentum returns, margin recovery is the test
Hatsun eyes double-digit growth in Q2 after a strong Q1 topline (+19%), but milk cost pressures must ease for profit to keep up. Street values the stock below current levels; valuations and execution will frame the quarter.
The quarter at a glance
Hatsun Agro enters Q2 FY27 on the back of a record Q1 topline—revenue broke ₹3,000 Cr for the first time, posting 19.3% growth to ₹3,090 Cr. But the print told a cautionary tale: profit after tax essentially flatlined, rising just 1% YoY to ₹134 Cr, as raw milk procurement costs ate into margins. This sets up Q2's real test: can the company hold revenue growth while stabilizing profit? On-plan expectations hinge on two things—continued strong milk demand and modest input cost relief.
~₹3,150 Cr
Q1 posted ₹3,090 Cr (+19.3% YoY); modest Q2 step expected at +16–20% run-rate, tracking guidance
₹140–160 Cr
Critical: Q1 margin squeeze (19% revenue growth but PAT +1%) must reverse. Better milk cost trajectory is essential
~18–20%
FY26 was ~17–18%. Q1 compression signals input inflation; recovery timing unclear
What a strong print looks like: revenue maintains +15% YoY momentum, PAT grows 8–12% YoY (margin ~4.5%), and management reiterates the ₹120 Bn full-year run-rate (implying strong H2 tracking). What weak looks like: revenue growth dips below +12% YoY, PAT flat to negative YoY, and any margin guidance warning signals persistent milk cost headwinds.
On track with guidance?
Hatsun's stated 2-year ambition is 50% revenue growth to ₹120 Bn this fiscal (FY27). That implies a full-year run-rate of ~₹30 Bn (₹120 Bn ÷ 4). H1 FY27 has delivered ₹3,090 Cr in Q1 alone; Q2 tracking at ₹3,150–3,250 Cr would put H1 at ~₹6,250 Cr, leaving ₹5,750 Cr to earn in H2—feasible but requires consistent momentum. The risk: if input costs remain sticky, margin recovery delays, and profit growth lags the topline target. Management signaled no new guidance issues in recent filings, so the bar is execution on volume + mix.
What the Street says
Since Q1: recent filings and moves
Hatsun has been active on growth and governance fronts:
Oct 14
Q2 results approval set for Oct 22, 2026 (tomorrow)
Board Meeting Scheduled
Oct 12
Reaffirmed 50% revenue growth target over 2 years; FY27 run-rate ₹120 Bn expected. Underscores confidence in scale agenda.
Business Update
Sep 28
'Go-Dhan' initiative with Odisha Govt & SBI to empower dairy farmers. Supports supply chain expansion in key region.
Partnership
Sep 11
CRISIL ESG Score 58 assigned. Reflects governance rigor and sustainability positioning.
ESG Rating
Sep 11
RG Chandramogan & PACs acquired 96,000 shares (+0.04%), signal of confidence at ₹1,192/share (then trading higher).
Promoter Acquisition
Aug 05
₹1,000 Cr capex commitment for FY27 expansion (milk procurement, dairy facilities). Validates growth infrastructure bet.
Capex Guidance
No material adverse events. Promoter buying near highs (Sep 11 at ₹1,192) signals conviction, though broader block activity (earlier Raju/Ravi Kirti Shah sells at ₹1,192 in Jul) underscores normal liquidity. Trading window closure is routine pre-result governance.
What to watch on Oct 22
1 · Revenue growth rate
Watch for maintenance of +15% YoY momentum or reacceleration above Q1's +19.3%. Any dip below +12% signals demand softness or channel pullback.
2 · Margin recovery signal
Critical: PAT growth should exceed revenue growth (reverse the Q1 squeeze). Look for EBITDA margin commentary—any guidance that milk costs will remain sticky through Q3 is a headwind for full-year PAT estimates.
3 · FY27 guidance reaffirmation
Management will likely restate the ₹120 Bn run-rate target. Watch for any caveat on input costs, capex phasing, or geographic expansion pace.
4 · Capex progress
Q1 capex details (if disclosed). ₹1,000 Cr annual plan implies steady deployment. Any acceleration or slowdown signals infrastructure confidence.
5 · Regional / segment color
Milk, ice cream, and other value-added products performance. Geographic mix (North/South dairy penetration, national ice cream footprint) will hint at durability of growth.
The setup
Hatsun is at an inflection: the topline story is intact (19% Q1 growth, strong demand, ₹120 Bn FY27 guidance on track), but margins are under pressure (Q1 PAT near-flat despite 19% revenue growth). Q2 is the test of whether milk input costs will stabilize, allowing the company to leverage volume growth into profit expansion. At ₹1,145, the stock is priced 22% above Street consensus (₹935), implying investors have already priced in margin recovery and execution on the 2-year growth agenda. Miss on PAT, and valuation downside is material. Deliver on profit growth + guidance, and there's room for target upgrades. Oct 22 will settle which narrative holds.
Hatsun Agro's Q2 FY27 preview hangs on one central question: can the company maintain its 19% Q1 revenue growth while reversing the margin squeeze? The topline momentum is real—crossing ₹3,000 Cr quarterly, backed by strong milk demand and capex expansion. But Q1's profit flatline amid 19% revenue growth is the red flag. Dairy input costs have been inflationary, and until there's evidence of either cost stabilization or pricing power, the Street's conservative ₹935 consensus target will loom over the stock's 22% premium valuation. Watch for PAT growth that scales with revenue, reaffirmation of the ₹120 Bn FY27 run-rate, and management color on milk cost trajectory through H2. If margins recover, the growth thesis re-rates higher; if they stay squeezed, value concerns surface.
Hatsun Agro's standalone Q2 FY27 PAT grows just 5.6% YoY to ₹115.69 Cr as 19.4% revenue growth meets milk-cost margin squeeze
PAT +5.61% YoY · revenue +19.37% · margins compressing
₹2,897.64 Cr
+19.37% YoY
₹115.69 Cr
+5.61% YoY
3.99%
-0.5pp YoY
₹5.19
Hatsun Agro Product's standalone Q2 FY27 (quarter ended September 30, 2026) revenue from operations rose 19.4% year-on-year to ₹2,897.64 Cr from ₹2,427.59 Cr, continuing the momentum seen in Q1 FY27 (+19.3% YoY). But profit after tax grew only 5.6% YoY to ₹115.69 Cr from ₹109.54 Cr — profit growth lagging revenue growth by a wide margin, the defining feature of the quarter. Sequentially, revenue fell 6.2% from Q1 FY27's record ₹3,090.49 Cr and PAT fell 13.5% from ₹133.69 Cr; for a dairy and ice-cream business, Q1 (April-June) is seasonally the stronger quarter, so the QoQ decline is a seasonality artifact rather than a demand slowdown and should not be read as weakness on its own.
Q2 FY-2027 vs prior quarters
The gap between revenue and profit growth sits on margins: operating profit margin (PBT + finance cost + depreciation, net of other income, over revenue) came in at 11.44%, versus 13.39% a year ago — roughly 195 bps of YoY compression — while net profit margin fell to 3.99% from 4.51% YoY and 4.32% in Q1 FY27. Raw material (milk procurement) cost pressure, flagged as the central risk ahead of this print, has not eased: cost of raw materials consumed rose to ₹2,050.69 Cr (70.7% of total income) from ₹1,469.25 Cr (60.4%) a year ago, even as OPM held roughly flat quarter-on-quarter against Q1 FY27's 11.35%. A higher effective tax rate of 24.1% (vs 21.7% in Q1 FY27) added further to the sequential profit squeeze.
The stock went into the print at ₹1,072.9, down 5.1% over the past month of trading.
What the summary numbers don't show
Statutory auditor issued an unmodified review conclusion — no exceptional items or minority interest adjustments this quarter.
Going into this result, Stockwatch's own pre-result preview had flagged margin recovery as "the test" for the quarter, with on-plan expectations of ~₹3,150 Cr revenue, ₹140-160 Cr PAT and 18-20% EBITDA margin. The actual print missed on all three: revenue came in about 8% light, PAT missed even the bottom of the range by roughly 17%, and EBITDA margin (PBT + finance cost + depreciation as a share of revenue, ~11.6%) landed well short of the 18-20% band — confirming the margin recovery the Street was watching for did not materialise this quarter. The stock had been trading at ₹1,145.6 as of October 15, a 22% premium to the median analyst target of ₹935 (Neutral consensus, 1 Buy/1 Sell), pricing in exactly this kind of margin improvement; this print does not supply it. We could not find a sell-side consensus estimate specifically for this quarter's revenue/PAT via web search, so vsStreet is assessed against our own preview rather than a brokerage poll. Separately, the company paid its first interim dividend for FY27 — ₹10 per share (1000%), aggregating ₹222.75 Cr — during H1, and continued capex (₹283.58 Cr in H1; capital work-in-progress up to ₹91.45 Cr from ₹58.62 Cr at FY26-end) toward the 50% two-year revenue growth target management outlined on October 12.
W1
Margin recovery still pending — OPM at 11.44% remains below the year-ago 13.39%; whether milk procurement cost pressure eases in H2 FY27 is the key lever to track.
W2
Capex execution toward the stated 50% two-year revenue growth target — capital work-in-progress at ₹91.45 Cr and H1 capex of ₹283.58 Cr; watch whether commissioning stays on schedule.
W3
No formal FY27 guidance is on record; watch for an explicit management outlook statement (concall/press release) to benchmark future quarters against.
Filing has no separate consolidated section — Hatsun's sole subsidiary (Milk Mantra Dairy) was merged into the company via NCLT order (appointed date Apr 1, 2025), so FY26 comparatives are restated figures; no exceptional items or minority interest; all pages legible and arithmetic ties out.